Bluebook
Pharma Services January 2019
2019 - January: Report on M&A and financing activity in the pharma services drug development industry for CEOs and private equity professionals
Crosstree BlueBooks provide an executive review of key health sciences transactions, financial movements, and public market activity. BlueBooks also offer a glimpse of how valuations are changing and how recent trends may affect future transactions.
- Transactions in the Pharma Services – Development industry totaled ten mergers & acquisitions and one financing during the month of January
- In terms of M&A, the Clinical Services and Laboratory Services sectors were the most active this month, with 5 transactions each; while in terms of financing, the Technology & Information Systems sector was the most active with 1 financing
- Total disclosed M&A value was $53 million during the month of January
- The largest disclosed M&A transaction this month was the $27 million acquisition of KAI Research by TAKE Solutions
- M&A and financings in the United States accounted for 90% of total transactions this month, up 80% from the previous month
- M&A activity this month includes acquisitions by Advent International, TAKE Solutions, Lambda Therapeutic Research, WIRB-Copernicus Group and ProPharma Group